These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16193387)

  • 1. Prolonged oral hydroxyurea and concurrent 3d-conformal radiation in patients with progressive or recurrent meningioma: results of a pilot study.
    Hahn BM; Schrell UM; Sauer R; Fahlbusch R; Ganslandt O; Grabenbauer GG
    J Neurooncol; 2005 Sep; 74(2):157-65. PubMed ID: 16193387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma.
    Mason WP; Gentili F; Macdonald DR; Hariharan S; Cruz CR; Abrey LE
    J Neurosurg; 2002 Aug; 97(2):341-6. PubMed ID: 12186462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyurea with or without imatinib in the treatment of recurrent or progressive meningiomas: a randomized phase II trial by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
    Mazza E; Brandes A; Zanon S; Eoli M; Lombardi G; Faedi M; Franceschi E; Reni M
    Cancer Chemother Pharmacol; 2016 Jan; 77(1):115-20. PubMed ID: 26659583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxyurea for recurrent surgery and radiation refractory meningioma: a retrospective case series.
    Chamberlain MC; Johnston SK
    J Neurooncol; 2011 Sep; 104(3):765-71. PubMed ID: 21318318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxyurea for recurrent surgery and radiation refractory high-grade meningioma.
    Chamberlain MC
    J Neurooncol; 2012 Apr; 107(2):315-21. PubMed ID: 22127733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea.
    Schrell UM; Rittig MG; Anders M; Koch UH; Marschalek R; Kiesewetter F; Fahlbusch R
    J Neurosurg; 1997 May; 86(5):840-4. PubMed ID: 9126900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of high risk or recurrent meningiomas with hydroxyurea.
    Rosenthal MA; Ashley DL; Cher L
    J Clin Neurosci; 2002 Mar; 9(2):156-8. PubMed ID: 11922703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hydroxyurea treatment for unresectable meningioma].
    Fuentes S; Chinot O; Dufour H; Paz-Paredes A; Métellus P; Barrie-Attarian M; Grisoli F
    Neurochirurgie; 2004 Sep; 50(4):461-7. PubMed ID: 15547484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensity-modulated radiation therapy (IMRT) for newly diagnosed and recurrent intracranial meningiomas: preliminary results.
    Sajja R; Barnett GH; Lee SY; Harnisch G; Stevens GH; Lee J; Suh JH
    Technol Cancer Res Treat; 2005 Dec; 4(6):675-82. PubMed ID: 16292888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spot-scanning proton radiation therapy for recurrent, residual or untreated intracranial meningiomas.
    Weber DC; Lomax AJ; Rutz HP; Stadelmann O; Egger E; Timmermann B; Pedroni ES; Verwey J; Miralbell R; Goitein G;
    Radiother Oncol; 2004 Jun; 71(3):251-8. PubMed ID: 15172139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benign meningioma: partially resected, biopsied, and recurrent intracranial tumors treated with combined proton and photon radiotherapy.
    Wenkel E; Thornton AF; Finkelstein D; Adams J; Lyons S; De La Monte S; Ojeman RG; Munzenrider JE
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1363-70. PubMed ID: 11121635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy.
    Hug EB; Devries A; Thornton AF; Munzenride JE; Pardo FS; Hedley-Whyte ET; Bussiere MR; Ojemann R
    J Neurooncol; 2000 Jun; 48(2):151-60. PubMed ID: 11083080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fractionated stereotactic radiation therapy in the management of benign cavernous sinus meningiomas : long-term experience and review of the literature.
    Milker-Zabel S; Zabel-du Bois A; Huber P; Schlegel W; Debus J
    Strahlenther Onkol; 2006 Nov; 182(11):635-40. PubMed ID: 17072520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined proton and photon conformal radiotherapy for intracranial atypical and malignant meningioma.
    Boskos C; Feuvret L; Noel G; Habrand JL; Pommier P; Alapetite C; Mammar H; Ferrand R; Boisserie G; Mazeron JJ
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):399-406. PubMed ID: 19203844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly conformal therapy using proton component in the management of meningiomas. Preliminary experience of the Centre de Protonthérapie d'Orsay.
    Noël G; Habrand JL; Mammar H; Haie-Meder C; Pontvert D; Dederke S; Ferrand R; Beaudré A; Gaboriaud G; Boisserie G; Mazeron JJ
    Strahlenther Onkol; 2002 Sep; 178(9):480-5. PubMed ID: 12426833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-resectable slow-growing meningiomas treated by hydroxyurea.
    Loven D; Hardoff R; Sever ZB; Steinmetz AP; Gornish M; Rappaport ZH; Fenig E; Ram Z; Sulkes A
    J Neurooncol; 2004; 67(1-2):221-6. PubMed ID: 15072471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxyurea chemotherapy in the treatment of meningiomas.
    Newton HB
    Neurosurg Focus; 2007; 23(4):E11. PubMed ID: 17961035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of fractionated stereotactic radiotherapy for intracranial skull base benign meningiomas in single institution.
    Onodera S; Aoyama H; Katoh N; Taguchi H; Yasuda K; Yoshida D; Surtherland K; Suzuki R; Ishikawa M; Gerard B; Terasaka S; Shirato H
    Jpn J Clin Oncol; 2011 Apr; 41(4):462-8. PubMed ID: 21177777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactically guided conformal radiotherapy for meningiomas.
    Alheit H; Saran FH; Warrington AP; Rosenberg I; Perks J; Jalali R; Shepherd S; Beardmore C; Baumert B; Brada M
    Radiother Oncol; 1999 Feb; 50(2):145-50. PubMed ID: 10368037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.